Zaltoprofen

COX-2 selective NSAID medication
  • US: Not FDA approved
  • Japan: Rx-only
Identifiers
  • 2-(6-Oxo-5H-benzo[b][1]benzothiepin-3-yl)propanoic acid
CAS Number
  • 74711-43-6
PubChem CID
  • 5720
DrugBank
  • DB06737
UNII
  • H8635NG3PY
CompTox Dashboard (EPA)
  • DTXSID0049076 Edit this at Wikidata
ECHA InfoCard100.070.863 Edit this at WikidataChemical and physical dataFormulaC17H14O3SMolar mass298.36 g·mol−13D model (JSmol)
  • Interactive image
  • CC(C1=CC2=C(C=C1)SC3=CC=CC=C3C(=O)C2)C(=O)O

Zaltoprofen (JAN; trade name Soleton) is a nonsteroidal anti-inflammatory drug (NSAID) used as an analgesic, antipyretic, and anti-inflammatory agent.[1] It is a selective COX-2 inhibitor and also inhibits bradykinin-induced pain responses without blocking bradykinin receptors.[2]

It was approved for use in Japan in 1993.[3]

References

  1. ^ "Zaltoprofen". drugs.com.
  2. ^ Hirate K, Uchida A, Ogawa Y, Arai T, Yoda K (April 2006). "Zaltoprofen, a non-steroidal anti-inflammatory drug, inhibits bradykinin-induced pain responses without blocking bradykinin receptors". Neuroscience Research. 54 (4): 288–94. doi:10.1016/j.neures.2005.12.016. PMID 16473424. S2CID 27367042.
  3. ^ "Zaltoprofen Launched in Japan". thepharmaletter.com. September 20, 1993.


  • v
  • t
  • e